Trial intelligence / Profile preview

Tacrolimus ER Dosing in Obese Kidney Transplant Recipients

NCT02444143Phase 4Completed

Sponsor
University of Illinois Chicago
Start
May 2015
Primary completion
Feb 2017
Modality
RNA-Targeting Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tacrolimus in kidney transplantation, sponsored by University of Illinois Chicago. Started May 2015; status: completed.

02

Drugs

tacrolimus
03

Conditions

kidney transplantation

Beyond the preview

Go deeper on NCT02444143.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02444143.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call